Annual Net Income
-$62.26 M
+$32.41 M+34.23%
31 December 2023
Summary:
Xeris Biopharma Holdings annual net profit is currently -$62.26 million, with the most recent change of +$32.41 million (+34.23%) on 31 December 2023. During the last 3 years, it has risen by +$28.89 million (+31.69%). XERS annual net income is now -371.31% below its all-time high of -$13.21 million, reached on 31 December 2016.XERS Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$15.74 M
-$733.00 K-4.89%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly net profit is currently -$15.74 million, with the most recent change of -$733.00 thousand (-4.89%) on 30 September 2024. Over the past year, it has dropped by -$3.55 million (-29.12%). XERS quarterly net income is now -238.52% below its all-time high of -$4.65 million, reached on 31 March 2017.XERS Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$63.11 M
-$3.55 M-5.96%
30 September 2024
Summary:
Xeris Biopharma Holdings TTM net profit is currently -$63.11 million, with the most recent change of -$3.55 million (-5.96%) on 30 September 2024. Over the past year, it has dropped by -$1.32 million (-2.13%). XERS TTM net income is now -1257.56% below its all-time high of -$4.65 million, reached on 31 March 2017.XERS TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.2% | -29.1% | -2.1% |
| 3 y3 years | +31.7% | +39.5% | +32.7% |
| 5 y5 years | -3.6% | +52.1% | +44.1% |
XERS Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +49.3% | -29.1% | +69.0% | -6.0% | +54.3% |
| 5 y | 5 years | -3.6% | +50.4% | -29.1% | +69.0% | -6.0% | +54.3% |
| alltime | all time | -371.3% | +50.4% | -238.5% | +69.0% | -1257.6% | +54.3% |
Xeris Biopharma Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.74 M(+4.9%) | -$63.11 M(+6.0%) |
| June 2024 | - | -$15.01 M(-20.9%) | -$59.56 M(-7.5%) |
| Mar 2024 | - | -$18.98 M(+41.7%) | -$64.40 M(+3.4%) |
| Dec 2023 | -$62.26 M(-34.2%) | -$13.39 M(+9.9%) | -$62.26 M(+0.7%) |
| Sept 2023 | - | -$12.19 M(-38.6%) | -$61.80 M(-13.5%) |
| June 2023 | - | -$19.84 M(+17.9%) | -$71.44 M(-8.2%) |
| Mar 2023 | - | -$16.83 M(+30.2%) | -$77.78 M(-17.8%) |
| Dec 2022 | -$94.66 M(-22.9%) | -$12.93 M(-40.8%) | -$94.66 M(-28.6%) |
| Sept 2022 | - | -$21.83 M(-16.6%) | -$132.52 M(-3.1%) |
| June 2022 | - | -$26.18 M(-22.3%) | -$136.70 M(-1.0%) |
| Mar 2022 | - | -$33.71 M(-33.6%) | -$138.03 M(+12.5%) |
| Dec 2021 | -$122.72 M(+34.7%) | -$50.79 M(+95.3%) | -$122.72 M(+30.8%) |
| Sept 2021 | - | -$26.01 M(-5.5%) | -$93.79 M(+11.9%) |
| June 2021 | - | -$27.52 M(+49.4%) | -$83.78 M(+4.3%) |
| Mar 2021 | - | -$18.41 M(-15.8%) | -$80.37 M(-11.8%) |
| Dec 2020 | -$91.14 M | -$21.86 M(+36.6%) | -$91.14 M(-11.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$16.00 M(-33.6%) | -$102.36 M(-14.1%) |
| June 2020 | - | -$24.10 M(-17.4%) | -$119.20 M(-7.9%) |
| Mar 2020 | - | -$29.18 M(-11.8%) | -$129.49 M(+3.1%) |
| Dec 2019 | -$125.58 M(+109.0%) | -$33.08 M(+0.7%) | -$125.58 M(+11.2%) |
| Sept 2019 | - | -$32.84 M(-4.5%) | -$112.92 M(+19.1%) |
| June 2019 | - | -$34.38 M(+36.0%) | -$94.85 M(+29.1%) |
| Mar 2019 | - | -$25.28 M(+23.8%) | -$73.45 M(+22.3%) |
| Dec 2018 | -$60.08 M(+126.3%) | -$20.42 M(+38.3%) | -$60.08 M(+23.1%) |
| Sept 2018 | - | -$14.77 M(+13.7%) | -$48.81 M(+17.4%) |
| June 2018 | - | -$12.99 M(+9.1%) | -$41.57 M(+22.9%) |
| Mar 2018 | - | -$11.91 M(+30.2%) | -$33.81 M(+27.3%) |
| Dec 2017 | -$26.55 M(+101.0%) | -$9.15 M(+21.5%) | -$26.55 M(+52.5%) |
| Sept 2017 | - | -$7.53 M(+43.9%) | -$17.41 M(+76.2%) |
| June 2017 | - | -$5.23 M(+12.5%) | -$9.88 M(+112.5%) |
| Mar 2017 | - | -$4.65 M | -$4.65 M |
| Dec 2016 | -$13.21 M | - | - |
FAQ
- What is Xeris Biopharma Holdings annual net profit?
- What is the all time high annual net income for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual net income year-on-year change?
- What is Xeris Biopharma Holdings quarterly net profit?
- What is the all time high quarterly net income for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly net income year-on-year change?
- What is Xeris Biopharma Holdings TTM net profit?
- What is the all time high TTM net income for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings TTM net income year-on-year change?
What is Xeris Biopharma Holdings annual net profit?
The current annual net income of XERS is -$62.26 M
What is the all time high annual net income for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual net profit is -$13.21 M
What is Xeris Biopharma Holdings annual net income year-on-year change?
Over the past year, XERS annual net profit has changed by +$32.41 M (+34.23%)
What is Xeris Biopharma Holdings quarterly net profit?
The current quarterly net income of XERS is -$15.74 M
What is the all time high quarterly net income for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly net profit is -$4.65 M
What is Xeris Biopharma Holdings quarterly net income year-on-year change?
Over the past year, XERS quarterly net profit has changed by -$3.55 M (-29.12%)
What is Xeris Biopharma Holdings TTM net profit?
The current TTM net income of XERS is -$63.11 M
What is the all time high TTM net income for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high TTM net profit is -$4.65 M
What is Xeris Biopharma Holdings TTM net income year-on-year change?
Over the past year, XERS TTM net profit has changed by -$1.32 M (-2.13%)